CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 209 filers reported holding CONMED CORP in Q3 2018. The put-call ratio across all filers is 2.46 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $710,829 | +20.7% | 6,491 | +11.1% | 0.02% | +9.1% |
Q3 2023 | $589,064 | -25.8% | 5,841 | 0.0% | 0.02% | -24.1% |
Q2 2023 | $793,733 | +30.8% | 5,841 | 0.0% | 0.03% | +20.8% |
Q1 2023 | $606,646 | +90988.0% | 5,841 | -22.2% | 0.02% | -14.3% |
Q4 2022 | $666 | -99.9% | 7,509 | -4.9% | 0.03% | -3.4% |
Q3 2022 | $633,000 | -48.2% | 7,900 | -38.0% | 0.03% | -43.1% |
Q2 2022 | $1,221,000 | -35.5% | 12,752 | 0.0% | 0.05% | -22.7% |
Q1 2022 | $1,894,000 | +6.2% | 12,752 | +1.4% | 0.07% | +11.9% |
Q4 2021 | $1,783,000 | +11.6% | 12,575 | +2.9% | 0.06% | +3.5% |
Q3 2021 | $1,598,000 | +6.8% | 12,218 | +12.2% | 0.06% | +5.6% |
Q2 2021 | $1,496,000 | +1.6% | 10,887 | -3.4% | 0.05% | -5.3% |
Q1 2021 | $1,472,000 | +20.1% | 11,269 | +2.9% | 0.06% | +14.0% |
Q4 2020 | $1,226,000 | +57.6% | 10,947 | +10.7% | 0.05% | +38.9% |
Q3 2020 | $778,000 | +9.3% | 9,889 | 0.0% | 0.04% | 0.0% |
Q2 2020 | $712,000 | +112.5% | 9,889 | +69.0% | 0.04% | +80.0% |
Q1 2020 | $335,000 | -33.4% | 5,850 | +30.0% | 0.02% | -13.0% |
Q4 2019 | $503,000 | +1.0% | 4,500 | -13.0% | 0.02% | 0.0% |
Q3 2019 | $498,000 | -1.8% | 5,175 | -12.7% | 0.02% | -4.2% |
Q2 2019 | $507,000 | +11.9% | 5,925 | +8.7% | 0.02% | +9.1% |
Q1 2019 | $453,000 | +29.4% | 5,450 | 0.0% | 0.02% | +10.0% |
Q4 2018 | $350,000 | -10.7% | 5,450 | +10.1% | 0.02% | 0.0% |
Q3 2018 | $392,000 | +15.3% | 4,950 | +6.5% | 0.02% | -9.1% |
Q2 2018 | $340,000 | +18.1% | 4,650 | +2.2% | 0.02% | +22.2% |
Q1 2018 | $288,000 | +29.7% | 4,550 | +4.6% | 0.02% | +28.6% |
Q4 2017 | $222,000 | -11.9% | 4,350 | -9.4% | 0.01% | -26.3% |
Q3 2017 | $252,000 | -8.4% | 4,800 | -11.1% | 0.02% | -13.6% |
Q2 2017 | $275,000 | +14.6% | 5,400 | 0.0% | 0.02% | +22.2% |
Q1 2017 | $240,000 | +0.4% | 5,400 | 0.0% | 0.02% | -10.0% |
Q4 2016 | $239,000 | +10.6% | 5,400 | 0.0% | 0.02% | -20.0% |
Q3 2016 | $216,000 | -30.3% | 5,400 | -16.9% | 0.02% | -30.6% |
Q2 2016 | $310,000 | – | 6,500 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 1,385,000 | $58,862,000 | 5.19% |
SIGNIA CAPITAL MANAGEMENT LLC | 146,589 | $6,230,000 | 2.32% |
HEARTLAND ADVISORS INC | 1,773,782 | $75,386,000 | 1.31% |
NORTH TIDE CAPITAL, LLC | 350,000 | $14,875,000 | 1.30% |
Aurora Investment Counsel | 38,196 | $1,623,000 | 1.07% |
INVESTMENT COUNSELORS OF MARYLAND LLC | 571,150 | $24,274,000 | 0.99% |
NEEDHAM INVESTMENT MANAGEMENT LLC | 102,500 | $4,356,000 | 0.90% |
Tributary Capital Management, LLC | 98,862 | $4,202,000 | 0.83% |
PERKINS CAPITAL MANAGEMENT INC | 27,850 | $1,184,000 | 0.80% |
Iguana Healthcare Management, LLC | 25,000 | $1,063,000 | 0.61% |